Skip to main content
logo
Ocular Therapeutix logo
Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
7.66
+0.12 (1.59%)
Oct 12, 2026, 11:47 AM EDT - Market open

Ocular Therapeutix Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
52.0651.9563.7258.4451.4943.52
Revenue Growth
-8.13%-18.47%9.03%13.49%18.32%150.08%
Gross Profit
-178.16-151.72-69.54-7.89-6.51-10.97
Operating Income
-313.91-270.02-160.88-82.38-78.65-78.04
Net Income
-301.45-265.94-193.51-80.74-71.04-6.55
Earnings Per Share
-1.41-1.42-1.22-1.02-0.97-0.98
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
598.64737.06392.1195.81102.3164.16
Total Debt
79.3876.9775.7883.3964.2858.98
Net Cash (Debt)
519.26660.09316.32112.4238.02105.18
Net Cash Growth
65.27%108.68%181.38%195.70%-63.86%-37.99%
Net Cash Per Share
2.433.532.001.310.461.28

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-238.24-204.88-134.68-70.23-59.6-65.55
Capital Expenditures
-16.86-12.01-1.29-6.09-3.72-1.19
Free Cash Flow
-255.1-216.89-135.97-76.32-63.32-66.74
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--292.04%-109.13%-13.51%-12.64%-25.20%
Operating Margin
-603.03%-519.75%-252.47%-140.96%-152.74%-179.31%
Pretax Margin
-579.09%-511.90%-303.67%-138.14%-137.95%-15.06%
Profit Margin
-579.09%-511.90%-303.67%-138.15%-137.95%-15.06%
FCF Margin
-490.06%-417.50%-213.37%-130.59%-122.96%-153.36%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
31.8149.7921.078.414.2012.27